Different effects of 26-week dietary intake of rapeseed oil and soybean oil on plasma lipid levels, glucose-6-phosphate dehydrogenase activity and cyclooxygenase-2 expression in spontaneously hypertensive rats.
We intended to determine whether or not dietary canola oil (CO) elevates plasma lipids and oxidative stress, since both of these are, possibly, related to the CO-induced life shortening through exacerbation of hypertension-associated vascular lesions found in stroke-prone spontaneously hypertensive rats (SHRSP). Spontaneously hypertensive rats (SHR) were used in this study to avoid a potential bias in the results due to the irregular death by stroke seen in SHRSP. SHR were fed for 26 weeks on a chow containing either, 10 wt/wt% of CO or soybean oil (SO), i.e., the control. Elevated plasma lipids and glucose-6-phosphate dehydrogenase (G6PD) activation in the liver and erythrocyte were found in SHR fed CO compared to that fed SO, while anti-oxidative enzymes other than G6PD were not activated. The CO diet brought about significant vascular lesions in the kidney, in which abundant cyclooxygenase-2 (COX-2) positive foci were immunochemically located in the juxtaglomerular apparatus. These results suggest that dietary CO induces a hyperlipidemic condition, in which G6PD may serve as an NADPH provider, and aggravates genetic diseases in SHR (also, probably, in SHRSP). The increased COX-2 expression indicates a role of renin-angiotensin-aldosterone system activation in the increased vascular lesions, whereas the effects of oxidative stress remain unclear.
Ohara
Naoki
N
Division of Toxicology, Hatano Research Institute, Food and Drug Safety Center, Ochiai 729-5, Hadano, Kanagawa 257-8523, Japan. ohara.n@fdsc.or.jp
Kasama
Kikuko
K
Naito
Yukiko
Y
Nagata
Tomoko
T
Saito
Yoshiaki
Y
Kuwagata
Makiko
M
Okuyama
Harumi
H
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000473:pathology; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology; D004912:Erythrocytes / Q000201:enzymology; D005229:Fatty Acids, Monounsaturated; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism*; D006973:Hypertension / Q000097:blood / Q000201:enzymology / Q000235:genetics; D007150:Immunohistochemistry; D007668:Kidney / Q000473:pathology; D008055:Lipids / Q000097:blood*; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008297:Male; D009206:Myocardium / Q000473:pathology; D010938:Plant Oils / Q000008:administration & dosage / Q000494:pharmacology*; D000074262:Rapeseed Oil; D051381:Rats; D011918:Rats, Inbred SHR; D013024:Soybean Oil / Q000008:administration & dosage / Q000494:pharmacology*
D001786:Blood Glucose; D052246:Cyclooxygenase 2 Inhibitors; D005229:Fatty Acids, Monounsaturated; D008055:Lipids; D010938:Plant Oils; D000074262:Rapeseed Oil; D013024:Soybean Oil; D005954:Glucosephosphate Dehydrogenase; D051546:Cyclooxygenase 2